Boris Peaker
Stock Analyst at Jones Trading
(2.21)
# 2,675
Out of 5,182 analysts
19
Total ratings
40%
Success rate
12.7%
Average return
Main Sectors:
Stocks Rated by Boris Peaker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLAY Relay Therapeutics | Initiates: Hold | $18 | $16.76 | +7.40% | 1 | Apr 14, 2026 | |
| MGNX MacroGenics | Downgrades: Hold | n/a | $3.46 | - | 3 | May 10, 2024 | |
| LNTH Lantheus Holdings | Initiates: Outperform | $100 | $83.82 | +19.30% | 1 | Dec 4, 2023 | |
| ADCT ADC Therapeutics | Downgrades: Market Perform | n/a | $4.28 | - | 1 | Nov 9, 2023 | |
| PCRX Pacira BioSciences | Upgrades: Outperform | $50 | $24.72 | +102.27% | 1 | Aug 3, 2023 | |
| PCVX Vaxcyte | Initiates: Outperform | n/a | $62.35 | - | 1 | Apr 18, 2023 | |
| XNCR Xencor | Initiates: Outperform | n/a | $13.06 | - | 1 | Dec 6, 2022 | |
| EBS Emergent BioSolutions | Maintains: Market Perform | $30 → $29 | $8.81 | +229.17% | 1 | Sep 12, 2022 | |
| CTMX CytomX Therapeutics | Downgrades: Market Perform | n/a | $4.82 | - | 2 | Jul 11, 2022 | |
| NKTR Nektar Therapeutics | Downgrades: Market Perform | n/a | $84.86 | - | 1 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.25 | - | 1 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $122.46 | - | 1 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $849.04 | - | 1 | Jun 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $95 → $102 | $119.07 | -14.34% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.19 | - | 1 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $31.55 | - | 1 | Oct 22, 2018 |
Relay Therapeutics
Apr 14, 2026
Initiates: Hold
Price Target: $18
Current: $16.76
Upside: +7.40%
MacroGenics
May 10, 2024
Downgrades: Hold
Price Target: n/a
Current: $3.46
Upside: -
Lantheus Holdings
Dec 4, 2023
Initiates: Outperform
Price Target: $100
Current: $83.82
Upside: +19.30%
ADC Therapeutics
Nov 9, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $4.28
Upside: -
Pacira BioSciences
Aug 3, 2023
Upgrades: Outperform
Price Target: $50
Current: $24.72
Upside: +102.27%
Vaxcyte
Apr 18, 2023
Initiates: Outperform
Price Target: n/a
Current: $62.35
Upside: -
Xencor
Dec 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $13.06
Upside: -
Emergent BioSolutions
Sep 12, 2022
Maintains: Market Perform
Price Target: $30 → $29
Current: $8.81
Upside: +229.17%
CytomX Therapeutics
Jul 11, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $4.82
Upside: -
Nektar Therapeutics
Mar 15, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $84.86
Upside: -
Mar 3, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $2.25
Upside: -
Jul 29, 2021
Initiates: Outperform
Price Target: n/a
Current: $122.46
Upside: -
Jun 12, 2017
Initiates: Outperform
Price Target: n/a
Current: $849.04
Upside: -
Jun 27, 2022
Maintains: Market Perform
Price Target: $95 → $102
Current: $119.07
Upside: -14.34%
Aug 13, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.19
Upside: -
Oct 22, 2018
Initiates: Outperform
Price Target: n/a
Current: $31.55
Upside: -